產(chǎn)品名稱 | β1,3半乳糖轉(zhuǎn)移酶3抗體 |
英文名稱 | Anti-B3GALNT1 |
規(guī)格 | 0.2ml/200μg |
濃度 | 1mg/1ml |
價(jià)格 | 來(lái)電可享受優(yōu)惠 |
英文名稱 Anti-B3GALNT1
中文名稱 β1,3半乳糖轉(zhuǎn)移酶3抗體
濃 度 1mg/1ml
規(guī) 格 0.2ml/200μg
抗體來(lái)源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit,Sheep
產(chǎn)品類型 一抗
研究領(lǐng)域 心血管 細(xì)胞生物
蛋白分子量 predicted molecular weight: 39kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from humanB3GALNT1
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 Preservative: 15mM Sodium Azide, Constituents: 1%BSA, 0.01M PBS, pH 7.4
產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
(石蠟切片需做抗原修復(fù))
not yet tested in other applications.
optimal dilutions/concentrations should be determined by theend user.
保存條件 Store at -152 °C for oneyear.
別 名 3-galactosyltransferase 3; 3-GalNAc-T1; 3-GalTase 3;3-N-acetylgalactosaminyltransferase 1; 3-N-acetylgalactosaminyltransferase;b3Gal T3; b3Gal-T3; B3galnt1; B3GALT3; B3GL1_HUMAN; Beta 1,3 galactosyltransferase3; Beta 1,3 GalTase 3; beta 1,3 N acetylgalactosaminyltransferase 1 (globosideblood group); Beta 3 GalNAc T1; Beta 3 Gx T3; Beta-1; Beta-3-Gx-T3; beta3GalT3; Beta3Gal-T3; Beta3GalT3; brainiac1; Galactosylgalactosylglucosylceramidebeta D acetyl galactosaminyltransferase; Galactosylgalactosylglucosylceramidebeta-D-acetyl-galactosaminyltransferase; galT3; Gb4Cer; GLCT3; GLOB; Globosidesynthase; globotriaosylceramide 3 beta N acetylgalactosaminyltransferase; Pantibody P antigen synthase; P blood group globoside; P1 antibody UDPGal:betaGlcNAc beta 1,3 galactosyltransferase 1; UDP Gal:betaGlcNAc beta 1,3galactosyltransferase, polypeptide 3 (Globoside blood group); UDP GalNAc:beta1,3 N acetylgalactosaminyltransferase 1; UDP GalNAc:betaGlcNAc beta 1,3galactosaminyltransferase, polypeptide 1 (Globoside blood group); UDP Nacetylgalactosamine:globotriaosylceramide beta 1,3 Nacetylgalactosaminyltransferase; UDP-GalNAc:beta-1;UDP-N-acetylgalactosamine:globotriaosylceramide beta-1